scispace - formally typeset
H

Ho-Jin Lee

Researcher at St. Jude Children's Research Hospital

Publications -  53
Citations -  2543

Ho-Jin Lee is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Wnt signaling pathway & Dishevelled. The author has an hindex of 22, co-authored 50 publications receiving 2254 citations. Previous affiliations of Ho-Jin Lee include Southwest Tennessee Community College & Kigali Institute of Science and Technology.

Papers
More filters
Journal ArticleDOI

Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled.

TL;DR: Differences in the binding affinity of the Dvl PDZ domain and its binding partners may be important in regulating signal transduction by Dvl, and these results identify a missing molecular connection within the Wnt pathway.
Journal ArticleDOI

PDZ domains and their binding partners: structure, specificity, and modification

TL;DR: The structural characterization of PDZ domains is discussed and the use of recently emerging technologies such as proteomic arrays and peptide libraries to study the binding properties ofPDZ-mediated interactions are discussed.
Journal ArticleDOI

Electrochemical cues regulate assembly of the Frizzled/Dishevelled complex at the plasma membrane during planar epithelial polarization

TL;DR: Results suggest that direct interaction between Fz and Dsh is stabilized by a pH and charge-dependent interaction of the DEP domain with phospholipids, which is particularly important for the PCP signalling branch and, thus, promotes specific pathway selection in Wnt signalling.
Journal ArticleDOI

Hydrogen Bonding Abilities of Thioamide

TL;DR: In this paper, the strengths of hydrogen bonding interaction between formamide (FA) and thioformamide (TFA) were investigated at the B3LYP level with the 6-311G(d,p), 6-31+G(m,p) and 6311++G(2d,2p) basis sets.
Journal ArticleDOI

Sulindac inhibits canonical Wnt signaling by blocking the PDZ domain of the protein Dishevelled.

TL;DR: The results suggest that the anticancer protective effect of sulindac (and its metabolite) reflect not only COX-1/2 inhibition but also the inhibition of abnormal canonical Wnt signaling via blockade of the Dvl PDZ domain.